Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Hepatology

• Publication date

  2007-11-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.22072PMID 18023026
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p53 and metabolism: Inside the TIGAR.

  2006cited by this paper
• Distinct activities of CHD1 and ACF in ATP-dependent chromatin assembly

  2005cited by this paper
• Chromosomal aberrations in esophageal squamous cell carcinoma among Chinese: gain of 12p predicts poor prognosis after surgery.

  2004cited by this paper
• Evaluation of BRCA2 in the genetic susceptibility of familial esophageal cancer

  2004cited by this paper
• Association of Vimentin overexpression and hepatocellular carcinoma metastasis

  2004cited by this paper
• Prognostic significance of c‐myc and AIB1 amplification in hepatocellular carcinoma

  2002cited by this paper
• Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer.

  2001cited by this paper
• Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization

  2001cited by this paper
• Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization

  2000cited by this paper
• Surfing the p53 network

  2000cited by this paper
• Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization

  2000cited by this paper
• Anticancer drug targets: cell cycle and checkpoint control.

  1999cited by this paper
• Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: Their relationship to clinicopathological features

  1999cited by this paper
• Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.

  1999cited by this paper
• Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1.

  1999cited by this paper
• CDK inhibitors: positive and negative regulators of G1-phase progression.

  1999cited by this paper
• Creation of human tumour cells with defined genetic elements

  1999cited by this paper
• The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma.

  1999cited by this paper
• Chromosomal aberrations associated with invasion in papillary superficial bladder cancer

  1998cited by this paper
• Molecular cytogenetics of primary breast cancer by CGH

  1998cited by this paper
• Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization

  1997cited by this paper
• Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer.

  1996cited by this paper
• DNA-binding and chromatin localization properties of CHD1

  1995cited by this paper
• Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions.

  1995cited by this paper
• An expanding family of helicases within the 'DEAD/H' superfamily.

  1993cited by this paper
• The yeast SNF2/SWI2 protein has DNA-stimulated ATPase activity required for transcriptional activation.

  1993cited by this paper

• High Expression of CHD1L, a Potent Oncogene Is Associated With Aggressive Head and Neck Cancer and Poor Survival Outcome.

  2026cites this paper
• Disrupted transcriptional networks regulated by CHD1L during neurodevelopment underlie the mirrored neuroanatomical and growth phenotypes of the 1q21.1 copy number variant

  2025cites this paper
• From Jumping Gene to Cancer: Revisiting the Role of JTB Protein

  2025cites this paper
• CHD1L in cancer and beyond: structure, oncogenic functions, and therapeutic potential

  2025influential citation
• Interference with CHD1L inhibits the malignant progression and enhances cisplatin sensitivity of ovarian cancer cells by binding PLK1

  2025cites this paper
• Targeted Inhibition of CHD1L by OTI-611 Reprograms Chemotherapy and Targeted Therapy-Induced Cell Cycle Arrest and Suppresses Proliferation to Produce Synergistic Antitumor Effects in Breast and Colorectal Cancer

  2025cites this paper
• PARP-ish: Gaps in Molecular Understanding and Clinical Trials Targeting PARP Exacerbate Racial Disparities in Prostate Cancer

  2024cites this paper
• Targeting ATP catalytic activity of chromodomain helicase CHD1L for the anticancer inhibitor discovery.

  2024cites this paper
• The validation of new CHD1L inhibitors as a therapeutic strategy for cancer

  2023cites this paper
• A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers

  2023cites this paper
• Metabolomics‐based classification reveals subtypes of hepatocellular carcinoma

  2022cites this paper
• The Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L

  2022cites this paper
• Role of genetic insights and tumor microenvironment in liver cancer: new opportunities for gene therapy

  2022cites this paper
• DNA Double Strand Break Repair and Its Control by Nucleosome Remodeling

  2022cites this paper
• Chromodomain Helicase DNA Binding Protein 1-like, a negative regulator of Forkhead box O3a, promotes the proliferation and migration of Angiotensin II-induced vascular smooth muscle cells

  2022cites this paper
• Molecular mechanisms underlying the activation of ALC1 nucleosome remodeling

  2022cites this paper
• Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer

  2022cites this paper
• Insights into the Possible Molecular Mechanisms of Resistance to PARP Inhibitors

  2022cites this paper
• Role of chromosome 1q copy number variation in hepatocellular carcinoma

  2021cites this paper
• Studying PAR-Dependent Chromatin Remodeling to Tackle PARPi Resistance.

  2021cites this paper
• The high expression of CHD1L and its clinical significance in human solid tumors

  2021cites this paper
• Diversity roles of CHD1L in normal cell function and tumorigenesis

  2021influential citation
• PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma

  2021cites this paper
• CHD1L augments autophagy-mediated migration of hepatocellular carcinoma through targeting ZKSCAN3

  2021cites this paper
• CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2/B1-nmMYLK axis

  2021cites this paper
• Multiple‐level copy number variations in cell‐free DNA for prognostic prediction of HCC with radical treatments

  2021cites this paper
• Multiple roles for PARP1 in ALC1-dependent nucleosome remodeling

  2021cites this paper
• Therapeutic Potential of PARP Inhibitors in the Treatment of Gastrointestinal Cancers

  2021cites this paper
• CKS1B promotes the progression of hepatocellular carcinoma by activating JAK/STAT3 signal pathway

  2021cites this paper
• Structural basis of ALC1/CHD1L autoinhibition and the mechanism of activation by the nucleosome

  2021influential citation
• Gain of LINC00624 Enhances Liver Cancer Progression by Disrupting the Histone Deacetylase 6/Tripartite Motif Containing 28/Zinc Finger Protein 354C Corepressor Complex

  2020cites this paper
• Systematic analyses of genetic variants in chromatin interaction regions identified four novel lung cancer susceptibility loci

  2020cites this paper
• The Controversial Roles of ADP-Ribosyl Hydrolases MACROD1, MACROD2 and TARG1 in Carcinogenesis

  2020cites this paper
• ALC1/eIF4A1-mediated regulation of CtIP mRNA stability controls DNA end resection

  2020cites this paper
• First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer

  2020influential citation
• Mechanistic Insights into Regulation of the ALC1 Remodeler by the Nucleosome Acidic Patch

  2020cites this paper
• The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment

  2020cites this paper
• Chromodomain-helicase-DNA-binding protein 1-like (CHD1L) silencing inhibits gastric cancer cell proliferation, invasion, and migration

  2020cites this paper
• Novel Insights Into Epigenetic Reprogramming and Destabilization of Pericentromeric Heterochromatin in Cancer

  2020cites this paper
• CHD1L promotes EOC cell invasiveness and metastasis via the regulation of METAP2

  2020cites this paper
• PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway

  2020cites this paper
• CHD1L promotes cell cycle progression and cell motility by up-regulating MDM2 in breast cancer.

  2019cites this paper
• ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.

  2019cites this paper
• Regulation of resection by chromatin associated proteins

  2019cites this paper
• CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma

  2019cites this paper
• CHD 1 L promotes cell cycle progression and cell motility by up-regulating MDM 2 in breast cancer

  2019influential citation
• ADP-ribosylation signalling and human disease

  2019cites this paper
• LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway

  2019cites this paper
• CHD1L contributes to cisplatin resistance by upregulating the ABCB1–NF-κB axis in human non-small-cell lung cancer

  2019cites this paper
• Lymphoid enhancer-binding factor-1 promotes stemness and poor differentiation of hepatocellular carcinoma by directly activating the NOTCH pathway

  2019cites this paper
• Chromatin as a Platform for Modulating the Replication Stress Response

  2018cites this paper
• Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma

  2018cites this paper
• Chromatin remodeler ALC1 prevents replication-fork collapse by slowing fork progression

  2018cites this paper
• Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β‐catenin‐EGFR‐PI3K‐Akt‐mTOR signaling pathway

  2018influential citation
• Promotion of Insulin-like growth factor II in cell proliferation and epithelial–mesenchymal transition in hepatocellular carcinoma

  2018cites this paper
• Prognostic role of chromodomain helicase DNA binding protein 1-like protein in human solid cancers

  2018cites this paper
• A Novel Regulatory Axis, CHD1L-MicroRNA 486-Matrix Metalloproteinase 2, Controls Spermatogonial Stem Cell Properties

  2018cites this paper
• Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers

  2018cites this paper
• Gain of UBE2D1 facilitates hepatocellular carcinoma progression and is associated with DNA damage caused by continuous IL-6

  2018cites this paper
• Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinoma

  2017cites this paper
• Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1

  2017cites this paper
• A Poly-ADP-Ribose Trigger Releases the Auto-Inhibition of a Chromatin Remodeling Oncogene.

  2017cites this paper
• The multifaceted roles of PARP1 in DNA repair and chromatin remodelling

  2017cites this paper
• Identification of chemokine CXCL10 in tumor microenvironment by antibody array as a prognostic marker in hepatocellular carcinoma.

  2017cites this paper
• CHD1L Promotes Neuronal Differentiation in Human Embryonic Stem Cells by Upregulating PAX6

  2017cites this paper
• Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically downregulating MTSS1 through DNMT3B

  2016cites this paper
• Genetic alterations in hepatocellular carcinoma: An update

  2016cites this paper
• Systemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma

  2016cites this paper
• Overexpression of RNF2 Is an Independent Predictor of Outcome in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy

  2016cites this paper
• Identification of CHD1L as an Important Regulator for Spermatogonial Stem Cell Survival and Self-Renewal

  2016cites this paper
• Cell adhesion induces overexpression of chromodomain helicase/ATPase DNA binding protein 1-like gene (CHD1L) and contributes to cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma cells.

  2016cites this paper
• CHD1L Regulates Cell Cycle, Apoptosis, and Migration in Glioma

  2016cites this paper
• Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors

  2016cites this paper
• Disorders of Kidney Formation

  2016cites this paper
• Players in ADP-ribosylation: Readers and Erasers.

  2016cites this paper
• Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers

  2016cites this paper
• CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors

  2016cites this paper
• NOXIN as a cofactor of DNA polymerase‐primase complex could promote hepatocellular carcinoma

  2015cites this paper
• The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer.

  2015cites this paper
• CHD1L Regulated PARP1‐Driven Pluripotency and Chromatin Remodeling During the Early‐Stage Cell Reprogramming

  2015cites this paper
• Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival

  2015cites this paper
• Decaprenyl diphosphate synthase subunit 2 as a prognosis factor in hepatocellular carcinoma.

  2015cites this paper
• The molecular mechanism of PARP1 activationand its downstream roles in ALC1-regulatedtranscription

  2015cites this paper
• The Role of PARPs in DNA Strand Break Repair

  2015cites this paper
• REGULATION OF ALC1'S SNF2 ATPASE: INTERPLAY BETWEEN THE SNF2 DOMAIN, THE MACRODOMAIN AND OTHER CONSERVED ELEMENTS

  2015influential citation
• Investigation and characterisation of novel poly(ADP-ribose)-binding proteins in Dictyostelium discoideum

  2015cites this paper
• Title Overexpression of N-terminal kinase like gene promotes tumorigenicity of hepatocellular carcinoma by regulating cell cycle progression and cell motility

  2015cites this paper
• Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer

  2015influential citation
• Title Overexpression Of Chd 1 l Is Positively Associated With Metastasis Of Lung Adenocarcinoma And Predicts Patients Poor Survival

  2015cites this paper
• Overexpression of N-terminal kinase like gene promotes tumorigenicity of hepatocellular carcinoma by regulating cell cycle progression and cell motility

  2015cites this paper
• PARP-1 activation regulates the DNA damage response to DNA double-strand breaks

  2014cites this paper
• Presence of CHD1L Over-Expression Is Associated with Aggressive Tumor Biology and Is a Novel Prognostic Biomarker for Patient Survival in Human Breast Cancer

  2014influential citation
• Poly(ADP-ribosyl)ation in regulation of chromatin structure and the DNA damage response

  2014cites this paper
• The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update

  2014cites this paper
• CHD1L is a novel independent prognostic factor for gastric cancer

  2014influential citation
• Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial‐mesenchymal transition by way of Akt/GSK‐3β/Snail signaling

  2014cites this paper
• Chromodomain helicase/ATPase DNA binding protein 1-like protein expression predicts poor prognosis in nasopharyngeal carcinoma

  2014cites this paper
• Exploration of liver cancer genomes

  2014cites this paper
• Homeobox B9 is overexpressed in hepatocellular carcinomas and promotes tumor cell proliferation both in vitro and in vivo.

  2014cites this paper
• Overexpression of CDC28 protein kinase regulatory subunit 1B confers an independent prognostic factor in nasopharyngeal carcinoma

  2014cites this paper